Clinical Trial Update: The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment

View source ↗

Summary

A completed clinical trial evaluating copper parameter assessment in Wilson disease participants receiving standard of care treatment; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilson Disease

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Wilson Disease | Status: COMPLETED | Results posted: 2020-10-26